Condition: Major Depressive Disorder (MDD) · Sponsor: Rotman Research Institute at Baycrest
The goal of this clinical trial is to test whether an accelerated deep Transcranial Magnetic Stimulation (dTMS) protocol can reduce depressive symptoms in older adults (ages 60-85) with Major Depressive Disorder (MDD) who have not tolerated or responded to antidepressant medications. The study will evaluate whether accelerated dTMS administered over 5 consecutive days is safe and well-tolerated in this population, and whether it produces greater reductions in depressive symptoms compared to placebo stimulation.
This description comes directly from the study's public registry record.
Amanda Chao, MPH · 416-785-2500 · preventad@research.baycrest.org
Linda Mah, MD · 416-785-2500 · preventad@research.baycrest.org
Always discuss trial participation with your own doctor first.
| Rotman Research Institute at Baycrest | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07212465